A carregar...
Response to nab-paclitaxel and nedaplatin in a heavily-metastatic thymic carcinoma: A case report
Metastatic thymic carcinoma is an aggressive cancer that usually responds poorly to multimodal therapies. Although surgical resection is the preferred treatment for patients with advanced or metastatic disease, the clinical prognosis is typically poor. The present study describes a 63-year-old patie...
Na minha lista:
| Publicado no: | Oncol Lett |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
D.A. Spandidos
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4356389/ https://ncbi.nlm.nih.gov/pubmed/25789028 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2015.2953 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|